• While the cataractogenic effects of corticosteroids are beyond dispute, disagreement exists
concerning effects of total dose, intensity of dose, and duration of administration on cataract …

Introduction The relationship between long-term systemic corticosteroid therapy and the
development of posterior subcapsular cataracts (PSC) has been reviewed by Straatsma. 1 …

The association linking corticosteroid therapy with the development of posterior subcapsular
cataracts has been well documented. These drugs are widely used therapeutically …

A group of 56 patients who had received sustained, systemic corticosteroid therapy were
examined in order to determine the incidence of posterior subcapsular cataracts. Thirty-eight …

The prevalence of PSCC in the general population may be estimated with fair accuracy.
Considering only patients 65 years of age or older, 0.3 percent of the hospital beds of Great …

Background The use of systemic corticosteroids is a risk factor for the development of
posterior subcapsular cataracts, but the association between inhaled corticosteroids and …

Prolonged use of glucocorticoids is a significant risk factor for the development of posterior
subcapsular cataract. This places restrictions on the use of glucocorticoids in the treatment …

Centrally placed opacities lying under the capsuleatthe posteriorpart of the lens-posterior
subcapsular cataracts (PSC)-have beenreported in 12.5 to 6o per cent.(mean 36-7 per cent.) …

OBJECTIVE:: Longitudinal associations between inhaled and oral corticosteroid use and 10-
year incident cataract were examined. DESIGN: Population-based cohort study …

A previous communication by the authors related the development of posterior subcapsular
cataracts (PSC) to long-term high dose corticosteroid therapy, 1 and a subsequent paper 2 …